Oculis Holding AG
OCSAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001953530
No open-market purchases or sales by Oculis Holding AG insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $1.16M in total; no superinvestor holds it.
Other share classesOCS
Q2 2023 vs. Q1 2023
How the institutions holding Oculis Holding AG changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 30 | 25 | −5 |
| Shares | 1.01M | 976.3K | −37.0K (−3.7%) |
| Value | $405.2K | $1.07M | +$669.7K (+165.3%) |
New holders (1)
Institutions that held Oculis Holding AG at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| MMCAP International Inc. SPC | 73,525 | $80.9K | 0.03% |
Sold out (6)
Institutions that held Oculis Holding AG at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Linden Advisors LP | 40,115 | $16.5K |
| Caas Capital Management LP | 33,333 | $14.2K |
| Dryden Capital, LLC | 15,000 | $5.04K |
| Castle Creek Arbitrage, LLC | 10,681 | $4.40K |
| CNH Partners LLC | 10,266 | $4.37K |
| Wolverine Asset Management LLC | 8,902 | $3.79K |